Almotriptan en es it fr

Almotriptan Brand names, Almotriptan Analogs

Almotriptan Brand Names Mixture

  • No information avaliable

Almotriptan Chemical_Formula


Almotriptan RX_link

Almotriptan fda sheet

Almotriptan FDA

Almotriptan msds (material safety sheet)

Almotriptan Synthesis Reference

No information avaliable

Almotriptan Molecular Weight

335.465 g/mol

Almotriptan Melting Point

No information avaliable

Almotriptan H2O Solubility

No information avaliable

Almotriptan State


Almotriptan LogP


Almotriptan Dosage Forms


Almotriptan Indication

For the treatment of acute migraine headache in adults

Almotriptan Pharmacology

Almotriptan is a selective 5-hydroxytryptamine receptor subtype agonist indicated for the acute treatment of migraine attacks with or without aura in adults. Almotriptan is not intended for the prophylactic therapy of migraine or for use in the management of hemiplegic or basilar migraine. Almotriptan is an agonist for a vascular 5-hydroxytryptamine receptor subtype (probably a member of the 5-HT1D family) having only a weak affinity for 5-HT1A, 5-HT5A, and 5-HT7 receptors and no significant affinity or pharmacological activity at 5-HT2, 5-HT3 or 5-HT4 receptor subtypes or at alpha1-, alpha2-, or beta-adrenergic, dopamine1,; dopamine2; muscarinic, or benzodiazepine receptors. This action in humans correlates with the relief of migraine headache. In addition to causing vasoconstriction, experimental data from animal studies show that Almotriptan also activates 5-HT1 receptors on peripheral terminals of the trigeminal nerve innervating cranial blood vessels, which may also contribute to the antimigrainous effect of Almotriptan in humans.

Almotriptan Absorption

No information avaliable

Almotriptan side effects and Toxicity

No information avaliable

Almotriptan Patient Information

No information avaliable

Almotriptan Organisms Affected

Humans and other mammals